In pediatric conditions involving moderate to severe pain it’s not uncommon for physicians to prescribe oxycodone or hydrocodone off label to their patients. But recent moves by Purdue Pharma (the manufacturer of popular opioid OxyContin) to seek FDA approval to … Continue reading